NEWS and RESOURCES​​​​​​​​​​​​

​​​

​​

• J&J’s innovative medicines carried Q3 as medtech disappoints, but newer medicines absent - by Annalee Armstrong (10/13/26)

​

• BioNTech faces 3rd mRNA setback as head and neck cancer therapy fails to improve survival - by Heather McKenzie (10/13/26)

​

• Roche expands obesity R&D footprint with Rona deal worth $1B+ - by Michael Gibney (10/13/26)

​

• Pfizer pens $500M Enodia pact to join Lilly in emerging protein degrader field - by Nick Paul Taylor (10/13/26)

​

• BARDA awards Kaléo $96M contract to deploy auto-injector for chemical threat preparedness - by Angus Liu (10/13/26)

​

​

Please contact us at nate@gloveportsolutions.com with any comments